Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Gain's initial data from its clinical study in parkinson's patients presented at an event
Date 09 October 2025

Gain's initial data from its clinical study in parkinson's patients presented at an event

Image Credit: Swisscore Announcement  Gain Therapeutics Inc., a leading clinical-level biotechnology company known for its development and exploratory-based next generation of allosteric smal...

Smith+Nephew's scientific data proves suitable for pressure injury prevention
Date 08 October 2025

Smith+Nephew's scientific data proves suitable for pressure injury prevention

Image Credit: Medical Device Network Announcement  Smith+Nephew, the leading medical technology business, is proud to introduce its new data created by Professor Amit Gefen and his research t...

Bial, in excellence race with its ongoing clinical trial
Date 07 October 2025

Bial, in excellence race with its ongoing clinical trial

Image Credit: Bial Announcement  Bial, a leading innovation-centric biopharmaceutical company targeting rare diseases and neurosciences, proudly mentioned its key progress in its current ACTI...

OS therapies' regulatory update in drug development submission procedure
Date 06 October 2025

OS therapies' regulatory update in drug development submission procedure

Image Credit: Drug Discovery and Development Announcement OS Therapies Inc., a leading antibody drug conjugate and clinical-stage cancer immunotherapy biotechnology company has informed a regulato...

Update alert for potential first-line pancreatic cancer registration study
Date 03 October 2025

Update alert for potential first-line pancreatic cancer registration study

Image Credit: Pancreatic Cancer Action Network Announcement Oncolytics Biotech Inc., a leading clinical-stage immunotherapy company, is establishing pelareorep, which has prompted an update on its...

Abbvie's NDA submission for tavapadon
Date 01 October 2025

Abbvie's NDA submission for tavapadon

Image Credit: Indian Pharma Post Announcement AbbVie, a leading biotech company, has proceeded with its submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for ...

Clene's new clinical data claims to improve brain energy metabolism
Date 30 September 2025

Clene's new clinical data claims to improve brain energy metabolism

Image Credit: Symbiosys Capital Management Announcement The Clene Inc., and its fully owned subsidiary Clene Nanomedicine Inc., a leading clinical stage biopharmaceutical company that targets mito...

Sandoz's iron sucrose injection, a new relief to US patients
Date 29 September 2025

Sandoz's iron sucrose injection, a new relief to US patients

Image Credit: India Pharma Outlook Announcement Sandoz, a known leader in producing affordable medicines, has entered the US with its generic iron sucrose injection with the approval of the US Foo...

Ncardia's ncyte to promote non-human primate cardiomyocytes
Date 26 September 2025

Ncardia's ncyte to promote non-human primate cardiomyocytes

Image Credit: Ncardia Announcement Ncardia, a known face in stem cell-related solutions for drug safety assessment and discovery, launched ncyte NHP-C vCardiomyocytes, the first ever available ven...

Sanofi's New Therapy Received a Regulatory Designation
Date 25 September 2025

Sanofi's New Therapy Received a Regulatory Designation

Announcement The US Food and Drug Administration (FDA) has granted Sanofi’s SAR446268 a fast-track designation. It is Sanofi’s one-time AAV gene therapy for non-congenital (adult and ju...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.